Biomea Fusion (BMEA) Prepaid Assets (2020 - 2026)
Biomea Fusion (BMEA) posted Prepaid Assets of $1.3 million for Q1 2026, down 43.88% sequentially from $2.2 million in Q4 2025, and up 661.21% YoY from $165000.0 in Q1 2025.
Biomea Fusion (BMEA) Prepaid Assets (2020 - 2026) Analysis & Trends
Biomea Fusion has reported Prepaid Assets for 7 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Prepaid Assets rose 661.21% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 661.21% YoY) and the FY2025 annual result came in at $2.2 million, down 77.74% from the prior year.
- Prepaid Assets fell to $1.3 million in Q1 2026 per BMEA's latest filing, from $2.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $10.1 million in Q4 2024 and troughed at $165000.0 in Q1 2025.
- A 5-year average of $3.2 million and a median of $2.6 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets tumbled 93.77% in 2025, then jumped 661.21% in 2026.
- Over 5 years, Prepaid Assets stood at $4.8 million in 2022, then sank by 51.47% to $2.3 million in 2023, then surged by 334.25% to $10.1 million in 2024, then plunged by 77.74% to $2.2 million in 2025, then tumbled by 43.88% to $1.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.3 million, $2.2 million, and $595000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 635,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 10.05 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Jun 30, 2023 | 3.03 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 4.77 Mn |
| Sep 30, 2022 | 5.40 Mn |
| Jun 30, 2022 | 4.51 Mn |
| Mar 31, 2022 | 2.22 Mn |
| Dec 31, 2021 | 3.05 Mn |
| Sep 30, 2021 | 1.70 Mn |